3MP-26332-83169
2 vaccinations
1 coded response
17 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 852 / AZ
- Registered
- 2020-12-30
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-30
Registered in v-safe
-
2020-12-30
Dose 1 — Pfizer-BioNTech
- 2020-12-30
- 2020-12-31
- 2021-01-01
- 2021-01-02
- 2021-01-03
- 2021-01-04
- 2021-01-05
- 2021-01-06
-
2021-01-13
Survey response — day 14, dose 1MedDRA: Nausea — Feeling: FairFree text: Constant nauseaMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-20
-
2021-01-21
Dose 2 — Pfizer-BioNTech
-
2021-01-28
Health check-in — day 7, dose 2Feeling: Fair · Site: Pain · Fatigue or tiredness, Nausea, Rash, not including the immediate area around the injection siteAdult check-in
- 2021-02-04
- 2021-02-11
- 2021-02-18
- 2021-02-25
- 2021-03-04
- 2021-04-22
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-30 | Pfizer-BioNTech | |
| 2 | 2021-01-21 | Pfizer-BioNTech |
Free text
Release 1 — day 14, dose 1
Symptoms: Constant nausea
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Nausea | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release